Informações:
Falhas:
ID
18939
Descrição
Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00084552
Link
https://clinicaltrials.gov/show/NCT00084552
Palavras-chave
Versões (1)
- 25/11/2016 25/11/2016 -
Transferido a
25 de novembro de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Prostate Cancer NCT00084552
Eligibility Prostate Cancer NCT00084552
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00084552
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Adenocarcinoma of prostate
Item
histologically confirmed adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
TNM clinical staging Palpation
Item
clinical stage t1b-t2c by palpation
boolean
C3258246 (UMLS CUI [1,1])
C0030247 (UMLS CUI [1,2])
C0030247 (UMLS CUI [1,2])
Prostate specific antigen measurement Pretreatment
Item
pretreatment prostate-specific antigen ≤ 20 ng/ml
boolean
C0201544 (UMLS CUI [1,1])
C3539075 (UMLS CUI [1,2])
C3539075 (UMLS CUI [1,2])
Gleason score
Item
gleason score ≤ 7
boolean
C3203027 (UMLS CUI [1])
erectile function Adequate International Index of Erectile Function Questionnaire
Item
suitable erectile function, defined as a response ≥ score 2 in question #1 of the international index of erectile function questionnaire
boolean
C0234606 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C3641331 (UMLS CUI [1,3])
C0205411 (UMLS CUI [1,2])
C3641331 (UMLS CUI [1,3])
Neoplasm Metastasis nodal | Neoplasm Metastasis Distant
Item
no clinical, radiographic, or pathologic evidence of nodal or distant metastatic disease
boolean
C0027627 (UMLS CUI [1,1])
C0443268 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C0443203 (UMLS CUI [2,2])
C0443268 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C0443203 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
performance status
Item
performance status
boolean
C1518965 (UMLS CUI [1])
Zubrod Performance Status
Item
zubrod 0-1
boolean
C3714786 (UMLS CUI [1])
Life Expectancy
Item
life expectancy
boolean
C0023671 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Function Hematopoietic
Item
hematopoietic
boolean
C0031843 (UMLS CUI [1,1])
C0229601 (UMLS CUI [1,2])
C0229601 (UMLS CUI [1,2])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Liver function
Item
hepatic
boolean
C0232741 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Renal function
Item
renal
boolean
C0232804 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Other
Item
other
boolean
C1516637 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,2])
Malignant Neoplasms | Skin carcinoma | Chronic Lymphocytic Leukemia Early stage | Small Cell Lymphoma Well Differentiated
Item
no other active malignancy within the past 5 years except nonmetastatic skin cancer or early-stage chronic lymphocytic leukemia (well-differentiated small cell lymphocytic lymphoma)
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0023434 (UMLS CUI [3,1])
C2363430 (UMLS CUI [3,2])
C0024303 (UMLS CUI [4,1])
C0205615 (UMLS CUI [4,2])
C0699893 (UMLS CUI [2])
C0023434 (UMLS CUI [3,1])
C2363430 (UMLS CUI [3,2])
C0024303 (UMLS CUI [4,1])
C0205615 (UMLS CUI [4,2])
Study Subject Participation Status Exclusion
Item
no other medical condition that would preclude study participation
boolean
C2348568 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,2])
Therapeutic procedure Concurrent
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
C0205420 (UMLS CUI [1,2])
Biological treatment
Item
biologic therapy
boolean
C1531518 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Chemotherapy
Item
chemotherapy
boolean
C0392920 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Hormone Therapy
Item
endocrine therapy
boolean
C0279025 (UMLS CUI [1])
androgen ablation Duration Calculated
Item
prior androgen-ablation therapy allowed provided total calculated duration ≤ 4 months
boolean
C1515985 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C1441506 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C1441506 (UMLS CUI [1,3])
Therapeutic radiology procedure
Item
radiotherapy
boolean
C1522449 (UMLS CUI [1])
Radiotherapy to pelvis
Item
no prior pelvic radiotherapy
boolean
C1536155 (UMLS CUI [1])
Operative Surgical Procedures
Item
surgery
boolean
C0543467 (UMLS CUI [1])
Operation on prostate Radical | Operation on prostate Radical Planned
Item
no prior or planned radical prostate surgery
boolean
C0194790 (UMLS CUI [1,1])
C0439807 (UMLS CUI [1,2])
C0194790 (UMLS CUI [2,1])
C0439807 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
C0439807 (UMLS CUI [1,2])
C0194790 (UMLS CUI [2,1])
C0439807 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])